Peptides for hangover recovery — the honest landscape

This is a hangover. You know what it is. What most people don't know is what it actually is — mechanistically, biologically — because the word hangover has been culturally handled as a character flaw with a cure that involves greasy breakfast food and waiting. The biology is more specific and more interesting than that, and it has implications for what may actually help and what is largely theater.

The hangover is not one thing. It is several overlapping physiological insults arriving simultaneously, which is why it feels so comprehensively terrible and why no single intervention reliably resolves it.

The first and most important mechanism is acetaldehyde toxicity. When your liver metabolizes ethanol, the first product is acetaldehyde — a compound that is meaningfully more toxic than alcohol itself. Acetaldehyde is cleared by the enzyme ALDH2, which converts it to acetate, which is relatively benign. But ALDH2 can only work so fast, and when alcohol intake exceeds the enzyme's clearing capacity, acetaldehyde accumulates. It causes nausea, facial flushing, rapid heart rate, and headache. It also damages tissue directly, including the gut lining. Many people with East Asian genetic backgrounds have a variant of ALDH2 that works less efficiently, producing more severe flushing and nausea with far smaller amounts of alcohol — a variant that also appears to be somewhat protective against alcohol dependence precisely because the experience is so unpleasant. But you don't need a genetic variant to accumulate acetaldehyde. You need enough alcohol and enough time.

Acetaldehyde depletes glutathione. This is the connection that has made the glutathione conversation relevant in the hangover recovery space. Glutathione is the body's primary endogenous antioxidant, and the liver uses it aggressively in the process of alcohol metabolism. Glutathione binds to acetaldehyde to form less toxic conjugates; by the time you're feeling the hangover, hepatic glutathione stores may be significantly depleted. This depletion matters not only for the immediate experience but for the broader oxidative stress load that follows a night of drinking. The rationale for glutathione — and for its precursor compounds — in the hangover context is rooted in this specific depletion mechanism.

The second mechanism is dehydration and electrolyte disturbance. Alcohol is a potent inhibitor of antidiuretic hormone (ADH), also called vasopressin — the hormone that tells your kidneys to retain water. With ADH suppressed, your kidneys excrete more water than you're taking in, even if you're drinking fluids. The electrolytes follow. Sodium, potassium, and magnesium losses accompany the fluid losses, and the consequence is not just thirst but the muscle cramping, light sensitivity, and amplification of headache that characterize a significant hangover. Rehydration addresses this mechanism directly, which is why it's the most consistently effective hangover intervention there is. It's also free.

The third mechanism is gastrointestinal irritation. Alcohol is directly irritating to the gastric mucosa. It increases acid secretion, disrupts the protective mucus layer of the stomach lining, and can, with sufficient intake, produce early signs of gastric inflammation. The nausea and upper abdominal discomfort of a hangover are partly explained by this direct irritant effect. At higher intake levels and with chronic drinking, there is also gut barrier disruption — increased permeability of the intestinal lining that allows bacterial products like lipopolysaccharide to translocate into systemic circulation, contributing to the inflammatory component.

And there is an inflammatory component. The post-acute alcohol state involves elevated pro-inflammatory cytokines — particularly IL-6, TNF-alpha, and IL-1beta. Measurable increases in circulating cytokines following heavy drinking have been documented in research, and the cytokine-mediated symptoms — fatigue, malaise, cognitive fog, body aches, light and sound sensitivity — are essentially indistinguishable from the early inflammatory response of a mild illness. This is not metaphorical. You feel sick after drinking heavily partly because, in a specific immunological sense, you are mounting a low-grade inflammatory response.

Sleep architecture disruption is the mechanism that explains the day-after fatigue that persists even when you slept eight hours. Alcohol disrupts REM sleep — acutely, consistently, dose-dependently. It suppresses REM in the first half of the night, then produces REM rebound in the second half, which is associated with vivid dreaming and fragmented light sleep. Slow-wave sleep is also compressed. The result is a night that occupied eight hours on the clock but delivered significantly less restorative sleep than those hours would have produced sober. You didn't rest. You were sedated and then partially restored.

Now, the peptide and supplement landscape.

Glutathione IV infusions are probably the intervention most aggressively marketed to the hangover-recovery crowd, and the mechanism is coherent. If glutathione depletion is a significant driver of acetaldehyde toxicity and oxidative stress during alcohol metabolism, then restoring glutathione should help. Intravenous delivery bypasses the poor oral bioavailability of glutathione supplements, which are substantially degraded in the gut. The evidence for IV glutathione specifically for hangover recovery is largely mechanistic and anecdotal — there are no robust clinical trials on hangover-specific glutathione infusion outcomes — but the biochemistry is not implausible. It is worth noting that the timing matters: glutathione is most useful if it's available during or shortly after alcohol metabolism, when acetaldehyde is being generated. A glutathione infusion the morning after is probably addressing residual oxidative stress rather than the peak acetaldehyde load.

N-acetylcysteine, or NAC, is a cysteine precursor that supports endogenous glutathione synthesis. It has better evidence than oral glutathione itself because it is better absorbed and because providing the precursor allows the liver to upregulate its own glutathione production. NAC has been studied and is researched for support in contexts of oxidative stress and acetaminophen toxicity — which involves similar mechanisms of glutathione depletion. For hangover specifically, the timing argument applies here too: taking NAC the morning after, when alcohol has largely been metabolized, may have more modest effects than taking it before or during drinking. Some protocols explore pre-drinking NAC; the evidence for this is preliminary and the timing is genuinely relevant to efficacy.

NAD+ is the other marquee ingredient in the IV hangover clinic menu, popularized as a cellular energy and longevity compound with a side-door association with alcohol recovery. The connection to alcohol metabolism is mechanistic: alcohol metabolism increases NADH relative to NAD+, shifting the NADH/NAD+ ratio and impairing numerous metabolic pathways that depend on NAD+ as a cofactor. Restoring NAD+ availability, in theory, could support faster metabolic normalization after drinking. NAD+ IV infusions have become a significant commercial product. The evidence specifically for hangover is limited; much of the NAD+ research is in contexts of addiction recovery, aging, and mitochondrial function rather than acute hangover intervention. The IV context at least solves the bioavailability problem that dogs oral NAD+ precursors.

BPC-157 has been researched in preclinical contexts — predominantly animal studies — for its effects on gut barrier integrity and gastric mucosal healing. Given that alcohol directly damages the gastric mucosa and may increase intestinal permeability, the mechanism has some logical relevance to the hangover context. The research here is preclinical, and the translation to human hangover recovery is speculative. BPC-157 is a research compound with no approved therapeutic indications, available through compounding channels, and the evidence does not yet support it as a hangover-specific intervention. The mechanistic logic is there; the clinical evidence is not.

B-vitamin repletion gets included in many hangover IV formulations, and the rationale is straightforward: alcohol depletes B vitamins, particularly thiamine, folate, and B12, and B vitamins are essential cofactors for the metabolic processes involved in alcohol metabolism and cellular energy production. This is less a peptide intervention than basic nutritional restoration, and its inclusion in IV cocktails is one of the more evidence-adjacent aspects of the IV hangover approach.

The IV hangover clinic itself deserves its own honest framing. The typical $200-500 infusion packages saline, electrolytes, B vitamins, sometimes glutathione, sometimes NAD+, sometimes an antiemetic. The evidence for the package is not uniform across its ingredients. The saline and electrolyte component has genuine evidence — it directly addresses dehydration and electrolyte disturbance, which are real mechanisms. The antiemetic has evidence. The B vitamins are reasonable nutritional support. The glutathione and NAD+ components have mechanistic logic but limited hangover-specific clinical evidence. You are paying a significant premium for an experience that is partly evidence-based rehydration and partly premium wellness packaging. That is not a reason to avoid it if you find it valuable and can afford it. It is a reason to understand what you're actually getting.

The honest framing is that prevention is the most effective hangover intervention, by a wide margin. Drinking less is obvious. Drinking water alongside alcohol — specifically, matching or approaching ethanol-driven fluid losses in real time — blunts dehydration significantly. Eating before and during reduces the rate of alcohol absorption and protects gastric mucosa. Choosing lower-congener beverages — congeners are the byproducts of fermentation and aging that are more concentrated in darker spirits and cheap wines, and that contribute significantly to hangover severity — meaningfully affects the next morning. Protecting sleep by not drinking in the four to five hours before bed allows alcohol to be more fully metabolized before sleep begins, reducing the REM disruption. None of this requires a peptide.

The practical hierarchy for hangover recovery, stripped of marketing, is: water and electrolytes first; food with protein and complex carbohydrate; rest; cautious use of NSAIDs for headache if your stomach tolerates them and if there are no contraindications (NSAIDs add their own gastric irritation layer); time. The peptide and IV clinic interventions are adjunctive to this, not substitutes for it, and their evidence quality varies enough that they should be understood as researched-for and potentially supportive rather than as reliably effective treatments.

The bigger conversation is what hangover frequency is telling you. An occasional hangover is a consequence of a social choice. Frequent hangovers are a signal worth taking seriously — not as moral judgment, but as metabolic information. The liver's glutathione reserves, the gut's mucosal integrity, the brain's inflammatory baseline, and the sleep architecture all accumulate damage with repeated heavy drinking exposures in a way that doesn't fully reset between episodes. The compound effect is measurable — in liver enzyme trends, in inflammatory markers, in cognitive benchmarks, in the subjective sense that recovery takes longer than it used to.

A hangover once in a while is the body doing its job with an unusual load. A hangover every weekend is the body telling you the load has become the baseline, and that the baseline is changing you.